XL092
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for XL092, covering 2024-11-19 to 2025-12-09. Get the full timeline:
Most recent: Clinical Trial Update: XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]